Cell cycle, cancer, and cell death Flashcards
G0 phase
quiescent, intact proliferation capacity, non-cycling
G1 phase (gap 1)
duration between completion of cell division and initiation of DNA replication, where cells start building cell mass
- growth and preparation
- RNA and protein synthesis also take place here. Organelles are duplicated
S-phase (synthesis)
DNA replication
multiple replication forks are activated on each chromosome
- then chromosomes are condensed into heterochromatin
- time during this phase is fairly constant across cell types
G2-phase (gap 2)
duration between completion of DNA replication and initiation of cell division
- preparation for nuclear division in mitosis
- there is a checkpoint that assess nuclear integrity, ensures that DNA is intact
M-phase
mitosis
- prophase, metaphase, anaphase, telophase
Cdc25
dephosphorylates the cyclin-CDK complex at its inhibitory site, activating the cyclin
CDK1
partners with cyclins A and B
triggers G2 –> M transition. Cyclin A is synthesized in S and destroyed starting at prometaphase
Cyclins B are synthesized in S/G2 and destroyed following the completion of chromosome attachment to the spindle
CKI (inhibitors p57, p27, p21) kip family
CDK2
cyclins A, E
Triggers G1 –> S transition
- stabilizes the replication complexes during DNA replication at the replication forks
CKI (inhibitors p57, p27, p21) Kip family
CDK4, CDK6
cyclin partner D
phosphorylation of the retinoblastoma susceptibility protein in G1. Triggers passage of the restriction point and cyclin E synthesis in some cell types. Extracellular growth factors control synthesis of D cyclins
CKI (inhibitor) - P16, p15, p18, p19 (INK family)
p16 CKI
Inhibits Cdk4 and Cdk6
Cooperates with retinoblastoma susceptibility protein in growth regulation. Altered in a high percentage of human cancers. This gene overlaps teh gene for p19, an important regulator of the p53 tumor suppressor protein.
p21 CKI
inhibits most CDK-cyclin complexes
- induced by p53 tumor suppressor. Cell-cycle arrest after DNA damage. Binds PCNA and inhibits DNA synthesis. Promotes cell cycle arrest in senescence and terminal differentiation. At low levels, may help assemble active Cdk-cyclin complexes
p27 CKI
inhibits most CDK-cyclin complexes
- cell cycle arrest in response to growth suppressors like TGF-B and in contact inhibition and differentiation.
cell cycle entry and progression
extracellular signals regulate cell cycle proteins and control growth
- Ras superfamily receive signals from catalytic receptors that have been activated by their ligand, overall effects of Ras signaling involve induction of proliferation
R point
restriction point, where cells commit to going through the cell cycle, regulated by retinoblastoma protein Rb
- unphosphorylated Rb inhibits E2F. Cyclin phosphorylate Rb, then CDK2/E hy[erphosphorylate Rb and it liberates E2F transcription factor
G2/M transtition
- activation of CDK1/cyclin B at the G2/M boundary, maintained by Cdc25
- CDk1/cyclin B translocate to the nucleus to initiate spindle assembly
- activated anaphase-promoting complex (APC) destroy CDk1 freeing cyclin B for degradation
G1 checkpoint
slow pathway:
- P21 binds and inhibits the CDk4/6/D.
- P21 is activated by P53 txn factor
- p21 and p53 are tumor suppressors
Faster pathway:
- activation of checkpoint kinase 2 and the inactivation of cdc25
- phosphates inactivating the cyclinD/CDK4/6 can no longer be removed and results in G1 arrest
G2 checkpoints
ATM pathway - ATM senses DNA damage and signals downstream
tumors
space occupying lesions that may or may not be neoplasms
neoplasm
relatively autonomous abnormal growth with abnormal gene regulation
2 types: benign and malignant (–> cancer)
cancer
malignant neoplasm (can produce metastasis)
Metastasis
secondary growth of cancer at different location from the primary neoplasm
Initiation
first step of carcinogenesis
- simple mutatino in one or more genes that control key regulatory pathways of the cell
Ex. genotoxic event (change in DNA sequence)
- irreversible, no threshold
- genotoxic agents such as chemicals, radiation, ROS, and viruses
- can be result of oncogenes or inactivation of tumor suppressor genes
promotion
second step of carcinogenesis
- selective functional enhancement of signal transduction pathways that were induced by initiator by continuous exposure
ex) . epigenetic event (involving changes in gene regulation) - occurs over a long period of time, can be reversible in its early stages
- gene activation or repression –> clonal expansion
- threshold for time and dosing
ex. ) inhibition of cell death
progression
third step of carcinogenesis
- continuing change of the basically unstable karyotype
ex) . clastogenic events and other (further changes in karyotypes) - further complex genetic changes (translocations, deletions, gene amplifications), irreversible changes in gene expression
- karyotype instability
- selection for optimal growth in response to cellular environment
- conversion of benign tumors into malignant neoplasms